mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
gossypol |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
Tamoxifen |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.3 |
mRNA |
betulinic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |